CN1123168A - Chinese medicine for curing aftereffect resulted from cerebral embolism - Google Patents
Chinese medicine for curing aftereffect resulted from cerebral embolism Download PDFInfo
- Publication number
- CN1123168A CN1123168A CN 94118274 CN94118274A CN1123168A CN 1123168 A CN1123168 A CN 1123168A CN 94118274 CN94118274 CN 94118274 CN 94118274 A CN94118274 A CN 94118274A CN 1123168 A CN1123168 A CN 1123168A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine
- radix
- resulted
- curing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The traditional Chinese medicine comprises 20-25% of Chinese angelica, 10-15% of fleece-flower root, 10-15% of the seed of Chinese dodder, 15-25% of root of achyranthes bidentata, 15-20% of fructus psoraleae and 10-15% of fruit of rubus. It can be made into pills or oral liquor. It has effect for invigorating blood-circulation and nourishing blood, and is indicated for treating diseases resulted from thrombus and encephalanalosis, hyperlipemia, prevention of apoplexy and anti-senility without toxic side effect.
Description
The present invention is a kind of Chinese medicine of curing cerebral infarction sequela, and being spreaded one's fame by numerous benefited patients is continuous life pellet.
At present, there is not specific drug for human cerebral embolism treatment of conditions, its treatment means is nothing more than some conventional treatments of " transfusion ", " oral western medicine ", " oral Chinese medicine " and the traditional Chinese medical science, though the curative effect that above-mentioned each method is had nothing in common with each other still has many places unsatisfactory.For example transfusion medicine commonly used generally adopts medicines such as " beniol ", " the anti-post enzyme of snake venom ", and its result or curative effect are not remarkable or pay effect obviously, and the infusion model price is higher simultaneously, and must possess the transfusion condition, so the patient accepts to be subjected to certain limitation; And for example oral western medicine mode medicine commonly used is " refined companion's sheet ", " vincamine tablet ", " Thebe woods " etc., its result or be some medicine effect still uncertainly, some medicine must be taken under electrocardiographic monitoring, while Western medicine price general charged costliness, and the patient takes for a long time and can cause heavier financial burden; Oral Chinese medicine is as " restorative bolus ", " DAHUOLUO DAN ", " Rhizoma Gastrodiae Pilulae " etc. for another example, then has curative effect also problem of ultra-high price slowly; Other for another example some conventional therapy means of the traditional Chinese medical science be difficult to obtain unified clinical effectiveness as Yin Shizhi person's maneuvers such as " acupuncture ", " massage " are different.
The object of the present invention is to provide a kind of Chinese medicine of special treatment cerebral infarction sequela, it has than above-mentioned each method of each medicine, and cost is low, price is low, and obvious results characteristics, the bearing of economic capability that helps the patient, also being applicable to the disease that brain atrophy, hyperlipidemia, high blood viscosity and all thrombosis cause simultaneously, is the new medicine that a kind of utmost point has DEVELOPMENT PROSPECT.
Technical scheme of the present invention: the continuous life of a kind of Chinese medicine is red, is used to cure cerebral infarction sequela, it is characterized in that it is by Radix Angelicae Sinensis 20-25%.The Radix Polygoni Multiflori 10-15%, field dobber 10-15%, Radix Achyranthis Bidentatae 15-25%, Fructus Psoraleae 15-20%, 10-15% composition of Fructus Rubi, above-mentioned prescription patent medicine can be pill or oral solutions.
The instructions of taking of the related Chinese medicine of the present invention: be generally every day three times, each potion, be about 20 days a conventional course of treatment, can receive significant curative effect in 120-180 days.
The therapeutic effect and the superiority of the related Chinese medicine of the present invention are: 1, the anaphase of cerebral infarction sequela and convalescent period are interior owing to be subjected to various situations, comprise influences such as emotion, environment, weather, so general medicine is difficult to reach the purpose of healing, this product is reused blood circulation promoting and enriching medicine, evident in efficacy and produce effects is fast, has exempted part patient can not be taken medicines such as Radix Ginseng, the Radix Astragali because of " not mending " worries; 2, blood circulation promoting and blood stasis dispelling, promotion of blood circulation, vessel softening, add the smart marrow of mending, be applicable to various diseases and brain atrophy that all thrombosis cause, diseases such as hyperlipidemia, high blood viscosity, have prevention " apoplexy " simultaneously and take place and recurrent effect, the body defying age is also had certain effect; 3, nontoxic, pair effect; 4, this product is with low cost, and taking convenience has the wide development prospect.
Further specify this medicine below in conjunction with embodiment.
Embodiment: get Radix Angelicae Sinensis 20%, the Radix Polygoni Multiflori 15%, field dobber 15%, Radix Achyranthis Bidentatae 20%, Fructus Psoraleae 15%, Fructus Rubi 15% adopts the medicine pill routine fashion to make honeyed pill, every ball 6-9 grams.
Claims (2)
1, a kind of Chinese medicine for the treatment of cerebral infarction sequela is characterized in that it is by Radix Angelicae Sinensis 20-25%, the Radix Polygoni Multiflori 10-15%, field dobber 10-15%, Radix Achyranthis Bidentatae 15-25%, Fructus Psoraleae 15-20%, 10-15% composition of Fructus Rubi, above-mentioned prescription patent medicine can be pill or oral solutions.
2, by the Chinese medicine of the said treatment cerebral infarction sequela of claim 1, the composition that it is characterized in that said honeyed pill is for getting Radix Angelicae Sinensis 20%, the Radix Polygoni Multiflori 15%, field dobber 15%, Radix Achyranthis Bidentatae 20%, Fructus Psoraleae 15%, Fructus Rubi 15%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94118274A CN1056283C (en) | 1994-11-19 | 1994-11-19 | Chinese medicine for curing aftereffect resulted from cerebral embolism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94118274A CN1056283C (en) | 1994-11-19 | 1994-11-19 | Chinese medicine for curing aftereffect resulted from cerebral embolism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1123168A true CN1123168A (en) | 1996-05-29 |
| CN1056283C CN1056283C (en) | 2000-09-13 |
Family
ID=5038732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94118274A Expired - Fee Related CN1056283C (en) | 1994-11-19 | 1994-11-19 | Chinese medicine for curing aftereffect resulted from cerebral embolism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1056283C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103417666A (en) * | 2012-05-22 | 2013-12-04 | 赵成喜 | Traditional Chinese medicine used for treating cerebral thrombus sequelae |
-
1994
- 1994-11-19 CN CN94118274A patent/CN1056283C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103417666A (en) * | 2012-05-22 | 2013-12-04 | 赵成喜 | Traditional Chinese medicine used for treating cerebral thrombus sequelae |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1056283C (en) | 2000-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN1055013C (en) | Method for prepn. of Chinese medicinal external application ointment for diminishing inflammation, stopping pain and setting fracture | |
| CN1056283C (en) | Chinese medicine for curing aftereffect resulted from cerebral embolism | |
| CN1056762C (en) | Brain-refreshing analgesic powder medicine | |
| CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
| CN1054765C (en) | External-use medicine bag for curing chronic gastritis and its prodn process | |
| CN1022165C (en) | Preparation and process of oral medicinal liquid for recuperating blood vessels | |
| CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1127664A (en) | External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof | |
| CN1090182A (en) | The vasculitic Chinese medicine of a kind of treatment | |
| CN1125580A (en) | Patent drug for anti-decrepitude | |
| CN1483455A (en) | Jiegudan medicine for rejoining bone | |
| CN1248465A (en) | Method for producing Anruneixiao medicinal liquid | |
| CN1060354C (en) | External-use medicine liquid 'Bishikang' for curing rhinitis | |
| CN1051005C (en) | Oral liquid for curing osteophyte | |
| CN1084398A (en) | Pill for supplementing qi and invigorating vasculum | |
| CN1058888C (en) | External-use ointment for treating pathological changes of intervertebral disc | |
| CN1069526C (en) | Medicine for curing hyperosteogeny | |
| CN1218686A (en) | Method for producing health medicinal wine | |
| CN1060074C (en) | Chinese patent drug for treating effevctively old and feeble type disease | |
| CN1068213C (en) | Medicine for treating hyperosteogeny, and lumbage and leg pain | |
| CN1111152A (en) | Medicated wine for treatment of arthralgia and its preparation | |
| CN1066067C (en) | Belt for regulating qi, activating collateral and protecting liver | |
| CN2229278Y (en) | Health belt with Chinese herb medicines for preventing and curing waist diseases | |
| CN1065437C (en) | Traditional Chinese medicine prescription for treating ischialgia disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |